DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Xolair (Omalizumab) - Current Clinical Trials

 
 



Xolair Related Clinical Trials

Efficacy and Safety of Omalizumab in Bullous Pemphigoid [Completed]

OIT and Xolair� (Omalizumab) in Cow's Milk Allergy [Active, not recruiting]

Non-invasive Ways to Evaluate Lung Disease After Treatment With Xolair [Completed]

The Effect of Xolair (Omalizumab) on Allergy Blood Cells [Completed]

A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA) [Completed]

Effect of Xolair on Airway Hyperresponsiveness [Active, not recruiting]

Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model [Completed]

Xolair Enhances Oral Desensitization in Peanut Allergic Patients [Completed]

A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels [Completed]

Xolair Treatment for Milk Allergic Children [Active, not recruiting]

Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria [Active, not recruiting]

Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations [Completed]

Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy [Completed]

Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma [Completed]

A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) [Completed]

Cold Urticaria Treatment With Xolair [Completed]

Role of Omalizumab in Reducing the Incidence of Oxaliplatin-induced Hypersensitivity Reaction [Recruiting]

A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab [Completed]

Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids [Completed]

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies [Completed]

An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) [Terminated]

A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy [Completed]

Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria [Completed]

Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients [Active, not recruiting]

Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria Patients [Completed]

A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma [Completed]

A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1) [Completed]

A Study of the Efficacy and Safety of Omalizumab (Xolair) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine (H1) Treatment [Completed]

Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis [Recruiting]

Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma [Completed]

Urticaria Facticia Treatment With Omalizumab (UFO) [Completed]

Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN) [Recruiting]

Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial [Active, not recruiting]

Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma [Completed]

Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome [Completed]

Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis [Withdrawn]

A Safety Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic Despite Treatment With H1 Antihistamines, H2 Blockers, and/or Leukotriene Receptor Antagonists [Completed]

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab [Terminated]

mRNA Expression as a Biomarker of Omalizumab Response [Not yet recruiting]

Omalizumab in Non-atopic Asthma [Recruiting]

Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization [Recruiting]

The Effect of Omalizumab on Responses to Cat Allergen Challenge [Completed]

Efficacy and Safety of Omalizumab in Patients With Severe Acute Urticaria [Not yet recruiting]

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma [Completed]

Exploratory Study of Xolair in Chronic Obstructive Pulmonary Disease in Patients With Elevated IgE Levels [Withdrawn]

Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Completed]

Xolair in Patients With Chronic Sinusitis [Completed]

Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus [Recruiting]

Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children [Completed]

Non-invasive Measures of Effects of Xolair in Asthma [Terminated]

Mode of Action Study of Omalizumab in Patients With Chronic Idiopathic Urticaria (CIU) Who Fail to Respond to Antihistamine Treatment [Completed]

Omalizumab in the Treatment of Peanut Allergy [Active, not recruiting]

Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis [Completed]

The Effects of Omalizumab (Anti-IgE) on the Late-phase Response to Nasal Allergen Challenge [Completed]

Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma [Completed]

Impact of Omalizumab on Quality of Life Measures and Angioedema Occurrence in Patients With CSU Refractory to Therapy [Completed]

Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic Urticaria [Active, not recruiting]

Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization [Recruiting]

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy [Completed]

Efficacy Study of Omalizumab in Cholinergic Urticaria [Recruiting]

Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma [Completed]

A Phase 2 Randomized, Controlled, Blinded Study Omalizumab With Oral Food Immunotherapy in Children and Adults With Multiple Food Allergies [Active, not recruiting]

Study of the Prednisone Sparing Effect of Xolair (Omalizumab) in Patients With Prednisone-dependent Asthma With Eosinophilic Bronchitis [Recruiting]

A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis [Recruiting]

Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma [Completed]

OPTIMA: Efficacy of Optimized Re-treatment and Step-up Therapy With Omalizumab in Chronic Spontaneous Urticaria (CSU) Patients [Recruiting]

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years) [Completed]

The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils [Active, not recruiting]

Treatment of Severe Peanut Allergy With Xolair (Omalizumab) and Oral Immunotherapy [Recruiting]

Role of Anti-IgE in Severe Childhood Eczema [Recruiting]

Inner-City Anti-IgE Therapy for Asthma [Completed]

The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients) [Completed]

Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [Recruiting]

Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma [Completed]

Atopic Dermatitis Biomarker Identification Trial in Omalizumab Usage [Completed]

Omalizumab in Severe and Refractory Solar Urticaria [Recruiting]

Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy [Active, not recruiting]

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists [Completed]

A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma [Completed]

Omalizumab for Lupus [Recruiting]

Immune Dysfunction in Allergic Asthma [Completed]

Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. [Completed]

An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g [Completed]

The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients [Active, not recruiting]

Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation. [Completed]

Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma [Completed]

Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma [Completed]

Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma [Active, not recruiting]

A Study to Assess the Efficacy and Safety of Omalizumab Through 48 Weeks in Participants With Chronic Idiopathic Urticaria (CIU) [Recruiting]

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing [Completed]

Omalizumab to Treat Hyper-IgE (Job's) Syndrome [Completed]

A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g [Completed]

Omalizumab to Treat Eosinophilic Gastroenteritis [Completed]

The REALITY Study - a Real-life Long-term Analysis of Xolair Therapy [Active, not recruiting]

Predicting the Clinical Response to Omalizumab With Anti-IgE Ab Response or Syk Expression in Basophils [Recruiting]

A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017